Lingyun Cheng

University of California System

H指数:34

被引数:4,610

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Potential of Fenofibric Acid as Topical Eye Drops for Management of Dry Eye Syndrome

芬尼酸作为治疗干眼症的眼用滴眼液的应用潜力

Pharmaceutics

IF5.5

2026-08-130

COMPARISON OF ULTRAHIGH-SPEED 250 kHz OCTA WITH HIGH-SPEED 125 kHz MODE USING HEIDELBERG SPECTRALIS SHIFT A Paired-Eye Analysis

超高斯速250 kHz OCTA与高速125 kHz模式（使用海德堡Spectralis SRA）的配对眼对比分析

Retina-The Journal of Retinal and Vitreous Diseases

IF2.1

2026-05-010

PRE

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ANALYSIS OF COHORT WITH PERIPAPILLARY CHOROIDAL NEOVASCULARIZATION

光学相干断层扫描血管成像分析周边视盘脉络膜新生血管队列

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

IF2.1

2025-12-010

PRE

Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis

Faricimab 在6 mg和12 mg剂量下可减少治疗抵抗性黄斑新生血管的色素上皮脱离：一项OCT和AI分析

Scientific Reports

IF3.9

2025-09-300

Dry eye disease treatment improves subjective quality-of-life responses in patients with AMD, independent of disease stage

干眼病治疗可改善AMD患者的自我主观生活质量反应，且与疾病分期无关。

PLOS ONE

IF2.6

2025-02-060

Synergistic effect of defocus incorporated multiple segment glasses and repeated low level red light therapy against myopia progression

离焦型多区正向离焦眼镜联合重复低强度红光疗法对近视进展的协同作用

SCIENTIFIC REPORTS

IF3.9

2025-02-010

OAAI

Mechanism of cigarette smoke in promoting small airway remodeling in mice via STAT 3 / PINK 1-Parkin / EMT

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2024-11-011

PRE

Comparison of manual versus automated thermal lid therapy with expression for meibomian gland dysfunction in patients with dry eye disease

SCIENTIFIC REPORTS

IF3.9

2024-09-271

OAAI

Effect of manual OCTA segmentation correction to improve image quality and visibility of choroidal neovascularization in AMD

SCIENTIFIC REPORTS

IF3.9

2024-06-182

OAAI

Effect of Thermoelectric Warming Therapy for the Treatment of Meibomian Gland Dysfunction

AMERICAN JOURNAL OF OPHTHALMOLOGY

IF4.2

2022-10-013

OAAI

Enhanced Oral NO Delivery through Bioinorganic Engineering of Acid-Sensitive Prodrug into a Transformer-like DNIC@MOF Microrod

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2022-01-1211

PRE

Changes of plasma nitric oxide, endothelin-1, and blood coagulation following intravitreal conbercept

SCIENTIFIC REPORTS

IF3.9

2021-12-130

OAAI

A sustained dual drug delivery system for proliferative vitreoretinopathy

用于增生性玻璃体视网膜病变的持续双重药物递送系统

DRUG DELIVERY

IF8.1

2020-10-267

OAAI

Intravitreal safety profiles of sol-gel mesoporous silica microparticles and the degradation product (Si(OH)4)

溶胶-凝胶介孔二氧化硅微粒和降解产物 (Si(OH)4) 的玻璃体内安全性

DRUG DELIVERY

IF8.1

2020-05-128

OAAI

Implication of inflammatory cytokines in the aqueous humour for management of macular diseases

ACTA OPHTHALMOLOGICA

IF2.8

2019-09-1823

OAAI

Sub-Tenon depository triamcinolone and glycaemic management in diabetic patients

ACTA OPHTHALMOLOGICA

IF2.8

2019-03-220

OAAI

Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy

基于多孔硅的玻璃体内平台，用于双重药物装载和控制释放以实现协同治疗

DRUG DELIVERY

IF8.1

2018-07-1118

OAAI

New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies

用于药物递送和药效学研究的兔增生性玻璃体视网膜病变新模型

DRUG DELIVERY

IF8.1

2018-02-2011

OAAI

A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation

DRUG DELIVERY

IF8.1

2017-11-085

OAAI

Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL)

ACTA BIOMATERIALIA

IF9.6

2016-06-0142

PREAI

Lingyun Cheng

个人简介

教育背景

工作经历

荣誉奖项

研究方向